Form 4: Roivant Sciences CFO Richard Pulik Sells Shares to Cover Tax Obligations

Roivant Sciences CFO Richard Pulik sold 1,896 common shares to cover tax obligations related to the vesting of restricted stock units.

Summary

• Richard Pulik, the CFO of Roivant Sciences Ltd., sold 1,896 common shares on January 28, 2025.
• The sale was executed at a price of $11.15 per share.
• This transaction was a 'net settlement' by the company to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
• Following the transaction, Mr. Pulik directly owns 270,680 common shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation and tax obligations. It is not indicative of any positive or negative sentiment towards the company's performance or outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It does not indicate any change in the company's outlook or performance.

Comparison to Industry Standards

• The sale of shares to cover tax obligations upon vesting of RSUs is a standard practice across publicly listed companies.
• Many companies use similar mechanisms to manage executive compensation and tax liabilities.
• The number of shares sold is relatively small compared to the total holdings of the CFO, suggesting this is a routine transaction.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• The sale does not indicate any change in the company's performance or outlook.

Key Dates

Keywords

Roivant Sciences, Richard Pulik, CFO, share sale, Form 4, insider trading, tax obligations, restricted stock units, equity compensation